121 related articles for article (PubMed ID: 30728210)
41. RORγt-Expressing Tregs Drive the Growth of Colitis-Associated Colorectal Cancer by Controlling IL6 in Dendritic Cells.
Rizzo A; Di Giovangiulio M; Stolfi C; Franzè E; Fehling HJ; Carsetti R; Giorda E; Colantoni A; Ortenzi A; Rugge M; Mescoli C; Monteleone G; Fantini MC
Cancer Immunol Res; 2018 Sep; 6(9):1082-1092. PubMed ID: 29991500
[TBL] [Abstract][Full Text] [Related]
42. Aberrant ICOS
Kälble F; Mai C; Wagner M; Schober L; Schaier M; Zeier M; Spratte J; Fluhr H; Steinborn A
Am J Reprod Immunol; 2016 Nov; 76(5):415-425. PubMed ID: 27650411
[TBL] [Abstract][Full Text] [Related]
43. Impairment of circulating CD4+CD25+ regulatory T cells in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Chi LJ; Wang HB; Wang WZ
J Peripher Nerv Syst; 2008 Mar; 13(1):54-63. PubMed ID: 18346231
[TBL] [Abstract][Full Text] [Related]
44. Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar origins.
Bui JD; Uppaluri R; Hsieh CS; Schreiber RD
Cancer Res; 2006 Jul; 66(14):7301-9. PubMed ID: 16849580
[TBL] [Abstract][Full Text] [Related]
45. B7-H1 and B7-H4 expression in colorectal carcinoma: correlation with tumor FOXP3(+) regulatory T-cell infiltration.
Zhao LW; Li C; Zhang RL; Xue HG; Zhang FX; Zhang F; Gai XD
Acta Histochem; 2014 Sep; 116(7):1163-8. PubMed ID: 25053455
[TBL] [Abstract][Full Text] [Related]
46. Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma.
Giraldo NA; Becht E; Vano Y; Petitprez F; Lacroix L; Validire P; Sanchez-Salas R; Ingels A; Oudard S; Moatti A; Buttard B; Bourass S; Germain C; Cathelineau X; Fridman WH; Sautès-Fridman C
Clin Cancer Res; 2017 Aug; 23(15):4416-4428. PubMed ID: 28213366
[No Abstract] [Full Text] [Related]
47. Resting and Activated Natural Tregs Decrease in the Peripheral Blood of Patients with Atherosclerosis.
Yazdani M; Khosropanah S; Hosseini A; Doroudchi M
Iran J Immunol; 2016 Dec; 13(4):249-262. PubMed ID: 27999237
[TBL] [Abstract][Full Text] [Related]
48. Tumor-infiltrating regulatory T cells are positively correlated with angiogenic status in renal cell carcinoma.
Ning H; Shao QQ; Ding KJ; Gao DX; Lu QL; Cao QW; Niu ZH; Fu Q; Zhang CH; Qu X; Lü JJ
Chin Med J (Engl); 2012 Jun; 125(12):2120-5. PubMed ID: 22884140
[TBL] [Abstract][Full Text] [Related]
49. Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.
Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; Du Z
Digestion; 2012; 86(4):329-37. PubMed ID: 23207161
[TBL] [Abstract][Full Text] [Related]
50. Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro.
Zhang HH; Mei MH; Fei R; Liao WJ; Wang XY; Qin LL; Wang JH; Wei L; Chen HS
Int J Oncol; 2010 Apr; 36(4):841-8. PubMed ID: 20198327
[TBL] [Abstract][Full Text] [Related]
51. Detection and Significance of CD4+CD25+CD127dim Regulatory T Cells in Individuals with Severe Aplastic Anemia.
Qi W; Ren Y; Fu R; Wang H; Liu C; Shao Z
Turk J Haematol; 2015 Sep; 32(3):220-7. PubMed ID: 25912955
[TBL] [Abstract][Full Text] [Related]
52. The effector T cell response to ryegrass pollen is counterregulated by simultaneous induction of regulatory T cells.
Mittag D; Scholzen A; Varese N; Baxter L; Paukovics G; Harrison LC; Rolland JM; O'Hehir RE
J Immunol; 2010 May; 184(9):4708-16. PubMed ID: 20308632
[TBL] [Abstract][Full Text] [Related]
53. Deregulated Mucosal Immune Surveillance through Gut-Associated Regulatory T Cells and PD-1
Fujimoto H; Saito Y; Ohuchida K; Kawakami E; Fujiki S; Watanabe T; Ono R; Kaneko A; Takagi S; Najima Y; Hijikata A; Cui L; Ueki T; Oda Y; Hori S; Ohara O; Nakamura M; Saito T; Ishikawa F
J Immunol; 2018 May; 200(9):3291-3303. PubMed ID: 29581358
[TBL] [Abstract][Full Text] [Related]
54. Tumor infiltration by T lymphocytes expressing chemokine receptor 7 (CCR7) is predictive of favorable outcome in patients with advanced colorectal carcinoma.
Correale P; Rotundo MS; Botta C; Del Vecchio MT; Ginanneschi C; Licchetta A; Conca R; Apollinari S; De Luca F; Tassone P; Tagliaferri P
Clin Cancer Res; 2012 Feb; 18(3):850-7. PubMed ID: 22142823
[TBL] [Abstract][Full Text] [Related]
55. The frequency of peripheral blood CD4+ CD25high FoxP3+ and CD4+ CD25- FoxP3+ regulatory T cells in normal pregnancy and pre-eclampsia.
Toldi G; Saito S; Shima T; Halmos A; Veresh Z; Vásárhelyi B; Rigó J; Molvarec A
Am J Reprod Immunol; 2012 Aug; 68(2):175-80. PubMed ID: 22510013
[TBL] [Abstract][Full Text] [Related]
56. Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells.
Sasidharan Nair V; Elkord E
Immunol Cell Biol; 2018 Jan; 96(1):21-33. PubMed ID: 29359507
[TBL] [Abstract][Full Text] [Related]
57. Altered regulatory T cell phenotype in latent autoimmune diabetes of the adults (LADA).
Radenkovic M; Silver C; Arvastsson J; Lynch K; Lernmark Å; Harris RA; Agardh CD; Cilio CM
Clin Exp Immunol; 2016 Oct; 186(1):46-56. PubMed ID: 27357431
[TBL] [Abstract][Full Text] [Related]
58. IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation.
Sim GC; Liu C; Wang E; Liu H; Creasy C; Dai Z; Overwijk WW; Roszik J; Marincola F; Hwu P; Grimm E; Radvanyi L
Cancer Immunol Res; 2016 Nov; 4(11):983-994. PubMed ID: 27697858
[TBL] [Abstract][Full Text] [Related]
59. Accelerated age-dependent transition of human regulatory T cells to effector memory phenotype.
Santner-Nanan B; Seddiki N; Zhu E; Quent V; Kelleher A; Fazekas de St Groth B; Nanan R
Int Immunol; 2008 Mar; 20(3):375-83. PubMed ID: 18195049
[TBL] [Abstract][Full Text] [Related]
60. Imbalance between Subpopulations of Regulatory T Cells in Patients with Acute Exacerbation of COPD.
Yang X; Huo B; Zhong X; Su W; Liu W; Li Y; He Z; Bai J
COPD; 2017 Dec; 14(6):618-625. PubMed ID: 29166179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
